Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Brain-derived neurotrophic factor (BDNF) signals through its high affinity receptor Tropomyosin receptor kinase-B (TrkB) to regulate neuronal development, synapse formation and plasticity. In rodents, genetic disruption of Bdnf and TrkB leads to weight gain and a spectrum of neurobehavioural phenotypes. Here, we functionally characterised a de novo missense variant in BDNF and seven rare variants in TrkB identified in a large cohort of people with severe, childhood-onset obesity. In cells, the E183K BDNF variant resulted in impaired processing and secretion of the mature peptide. Multiple variants in the kinase domain and one variant in the extracellular domain of TrkB led to a loss of function through multiple signalling pathways, impaired neurite outgrowth and dominantly inhibited glutamatergic synaptogenesis in hippocampal neurons. BDNF/TrkB variant carriers exhibited learning difficulties, impaired memory, hyperactivity, stereotyped and sometimes, maladaptive behaviours. In conclusion, human loss of function BDNF/TrkB variants that impair hippocampal synaptogenesis may contribute to a spectrum of neurobehavioural disorders.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
2045-2322
Volume Title
Publisher
Publisher DOI
Sponsorship
Wellcome Trust (207462/Z/17/Z)
Wellcome Trust (208363/Z/17/Z)
Wellcome Trust (100574/Z/12/Z)
Medical Research Council (MC_UU_12012/1)
Medical Research Council (MC_UU_12012/5)
Wellcome Trust (105602/Z/14/Z)
Wellcome Trust (211221/Z/18/Z)
MRC (MC_UU_00014/5)
MRC (MR/P501967/1)
Academy of Medical Sciences (SBF001\1016)
Medical Research Council (MC_PC_12012)